This summer, Medexprim received the European Commission’s Seal of Excellence for MIDAC (Medical Imaging Data Against Coronavirus), our project submitted to the EIC Accelerator COVID call. MIDAC’s goal was to constitute a centralized, collaborative and openly accessible Datalake of imaging exams and ancillary data with patients affected or not by Covid-19, and either release them to a qualified party for research, or help constitute synthetic control arms for existing clinical trials. This reinforces Medexprim’s position as a leader in the market of complex dataset creation & sourcing for clinical research, and encourages us to apply to the next “EIC Accelerator” call in October 2020, with a more ambitious project.

Together with leading EU university hospitals, with MIDAC, Medexprim’s mission was to facilitate the creation and enhancement of medical imaging databases and contextual data for research and for the development of new applications based on artificial intelligence.

Leveraging on this achievement, the Medexprim team is now applying the same approach to treatment against cancer and rare diseases. A great opportunity for our international partners to join our development dynamic !